Metraipolis › archive › dc_afc38acef79d
Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms — Europe PMC PMID:41517377
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41517377
- DOI
- 10.3390/jcm15010128
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T10:40:07.516Z
- SHA-256 of the archived text
6048c702fcd22125f4950cbd7d4aebda2ce0fcffc98daca86f830c497b63030c- Stable URL of this page
https://metraipolis.com/documento/dc_afc38acef79d
How to cite
Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms — Europe PMC PMID:41517377 — Europe PMC (en), https://europepmc.org/article/MED/41517377 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afc38acef79d (Metraipolis archive dc_afc38acef79d, sha256 6048c702fcd22125f4950cbd7d4aebda2ce0fcffc98daca86f830c497b63030c)
BibTeX
@misc{dcafc38acef79d,
title = {Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms — Europe PMC PMID:41517377},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41517377},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afc38acef79d; sha256 6048c702fcd22125f4950cbd7d4aebda2ce0fcffc98daca86f830c497b63030c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41517377. Agents can read the archived copy with the MCP tool read_document.